Building a foundation for precision health: M42 collaborates with Broad Institute, Microsoft & ICGD
M42 collaborates with the Broad Institute of MIT and Harvard, Microsoft, and the International Center for Genetic Disease to establish a framework for precision health, aiming to revolutionize patient outcomes globally, including in the UAE. By harnessing the capabilities of Terra, driven by Microsoft Azure, M42's Global Life Sciences Platform will drive international scientific investigations, with a focus on prioritizing preventive measures alongside curative approaches for enhancing global well-being.
M42 collaborates with the Broad Institute of MIT and Harvard, Microsoft, and the International Center for Genetic Disease to establish a framework for precision health, aiming to revolutionize patient outcomes globally, including in the UAE. By harnessing the capabilities of Terra, driven by Microsoft Azure, M42's Global Life Sciences Platform will drive international scientific investigations, with a focus on prioritizing preventive measures alongside curative approaches for enhancing global well-being.